Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The motilin receptor (MLNR), also known as GPR38 or MTLR1, is a G protein-coupled receptor that binds the peptide hormone motilin. It plays a central role in regulating gastrointestinal motility, particularly during fasting, by mediating contraction of smooth muscle cells in the stomach and small intestine during phase III of the migrating motor complex (MMC). It is predominantly expressed on enteric neurons, GI tract smooth muscle cells, and, in some species, endothelial cells.
Activation of Gq proteins leading to phospholipase C activation, IP₃ production, intracellular Ca²⁺ mobilization, and smooth muscle contraction; activation of PLC-IP₃-NOS-NO-sGC-cGMP cascade resulting in vasorelaxation
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Motilin Receptor (MLNR).